Medical News

RSS

TSRI researchers have new weapons to combat HIV

Scientists at The Scripps Research Institute have new weapons in the fight against HIV. Their new study, published November 17, 2015 as the cover article of the journal Immunity, describes four prototype antibodies that target a specific weak spot on the virus. Guided by these antibodies, the researchers then mimicked the molecular structure of a protein on HIV when designing their own potential HIV vaccine candidate.

18 Nov 2015

Loss of consciousness key outcome marker in SAH

A large study of patients with subarachnoid haemorrhage confirms loss of consciousness as a clinically important indicator of outcome.

17 Nov 2015

Minority patients seeking care in ED less likely to receive analgesic medication

New research indicates that minority patients seeking care in the emergency department were 22-30 percent less likely than white patients to receive analgesic medication.

17 Nov 2015

NSU collaborates with Karolinska Institutet to conduct cell-based biomedical research

Nova Southeastern University is now at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Sweden's world-renowned Karolinska Institutet (KI).

17 Nov 2015

MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

17 Nov 2015

PSA screening for prostate cancer drops significantly in middle-aged men

PSA testing has dropped significantly in middle-aged men after a 2012 recommendation that all men should not be routinely screened for prostate cancer, according to a new study published in the Journal of the American Medical Association.

17 Nov 2015

Researchers identify genetic mutation associated with reckless drunken behavior

University of Helsinki researchers have identified a genetic mutation which renders carriers susceptible to particularly impulsive and reckless behaviour when drunk. More than one hundred thousand Finns carry this mutation.

17 Nov 2015

VHI publishes new report on efficiency and productivity of hospitals, nursing homes

Virginia Health Information has published its 2015 report on the efficiency and productivity of hospitals and nursing homes. The report boils down mountains of data into key indicators of efficiency and productivity. The report was designed to meet the needs of large employers and purchasers of care.

17 Nov 2015

Horn Lake Family Practice named EHE-certified preventive care center

EHE International, a nationally recognized leader in preventive medicine and annual physical exams, announced today that Horn Lake Family Practice in Horn Lake, MS, has been named an EHE-certified preventive care center. Through Dr. Achin Sharma, EHE members in the Memphis region now have greater access to its preventive care program to help them proactively maintain their health.

17 Nov 2015

New Directions Behavioral Health launches Student Assistance Program to support campus counseling services

Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.

17 Nov 2015

HITLAB selects five finalists for HITLAB World Cup

HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.

17 Nov 2015

Vitamin E shows same efficacy in diabetic and nondiabetic patients

There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.

17 Nov 2015

BioSpa 8 automated incubator announced by BioTek

BioTek Instruments released the BioSpa™ 8 Automated Incubator, a unique platform that links microplate washers and dispensers with readers and imaging systems for unattended workflow automation.

17 Nov 2015

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to conduct a Phase 2 study of VK2809 in patients with hypercholesterolemia and fatty liver disease.

17 Nov 2015

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that the first patient has been enrolled into the Phase 2 clinical trial evaluating the safety and efficacy of its first in class fully human monoclonal antibody, bertilimumab in Ulcerative Colitis (UC).

17 Nov 2015

Mylan announces U.S. launch of generic AXERT tablets

Mylan N.V. today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXERT.

17 Nov 2015

Researchers use large-scale computer modeling to show effects of confinement on cell macromolecules

Using large-scale computer modeling, researchers have shown the effects of confinement on macromolecules inside cells -- and taken the first steps toward simulating a living cell, a capability that could allow them to ask 'what-if' questions impossible to ask in real organisms.

17 Nov 2015

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired -- permanently editing a gene, but only temporarily activating CRISPR-Cas9.

17 Nov 2015

Structural differences in key brain region linked to hallucinations in people diagnosed with schizophrenia

People diagnosed with schizophrenia who are prone to hallucinations are likely to have structural differences in a key region of the brain compared to both healthy individuals and people diagnosed with schizophrenia who do not hallucinate, according to research published today.

17 Nov 2015

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

17 Nov 2015

Medical News

TSRI researchers have new weapons to combat HIV

Loss of consciousness key outcome marker in SAH

Minority patients seeking care in ED less likely to receive analgesic medication

NSU collaborates with Karolinska Institutet to conduct cell-based biomedical research

MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

PSA screening for prostate cancer drops significantly in middle-aged men

Researchers identify genetic mutation associated with reckless drunken behavior

VHI publishes new report on efficiency and productivity of hospitals, nursing homes

Horn Lake Family Practice named EHE-certified preventive care center

New Directions Behavioral Health launches Student Assistance Program to support campus counseling services

HITLAB selects five finalists for HITLAB World Cup

Vitamin E shows same efficacy in diabetic and nondiabetic patients

BioSpa 8 automated incubator announced by BioTek

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Mylan announces U.S. launch of generic AXERT tablets

Researchers use large-scale computer modeling to show effects of confinement on cell macromolecules

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

Structural differences in key brain region linked to hallucinations in people diagnosed with schizophrenia

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News